Has David Lancaster, DO received payments from drug or device companies?

Yes. Drug and device makers reported $2,109 in general payments to David Lancaster, DO across 117 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean David Lancaster, DO did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about David Lancaster, DO come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

David Lancaster, DO

Physical Medicine & Rehabilitation · Jefferson City, MONPI 1114136686

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 117 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 38 manufacturers, the largest accounting for just 18.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $546 and has fallen 96.8% since, to $17 in 2024.

$2,109in general payments, 2019–2025

Across 117 payments — averaging $18.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$394
UCB, Inc.$181
EMD Serono, Inc.$134
Sanofi$128
Teva Pharmaceuticals USA, Inc.$102
Neurocrine Biosciences, Inc.$79
plus $1K from 32 others

What the payments were for

Food & beverage$2,109100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie(2 entities)	22	$394
UCB, Inc.	9	$181
EMD Serono, Inc.	5	$134
Sanofi	8	$128
Teva Pharmaceuticals USA, Inc.	7	$102
Neurocrine Biosciences, Inc.	4	$79
Grifols USA, LLC	4	$74
Mallinckrodt Hospital Products Inc.	4	$73
Bausch Health US, LLC	1	$72
Amneal Pharmaceuticals LLC	4	$63
AstraZeneca(2 entities)	3	$59
Johnson & Johnson(2 entities)	2	$58
Catalyst Pharmaceuticals, Inc.	3	$57
Biohaven Pharmaceutical Holding Company Ltd.	3	$55
Lundbeck LLC	3	$44
Lilly USA, LLC	3	$44
Sunovion Pharmaceuticals Inc.	3	$36
Amgen	2	$33
Mallinckrodt Enterprises LLC	2	$33
CSL Behring	2	$32
Ipsen Biopharmaceuticals, Inc	2	$29
Neurelis, Inc.	2	$29
Eisai Inc.	2	$29
Assertio Therapeutics, Inc.	2	$28
Upsher-smith Laboratories LLC	2	$28
Impel Pharmaceuticals Inc.	1	$22
Boston Scientific	1	$20
Argenx US, Inc.	1	$19
SK Life Science, Inc.	1	$19
Avanir Pharmaceuticals, Inc.	1	$19
Livanova USA, Inc.	1	$18
Sumitomo Pharma America, Inc.	1	$18
Medtronic	1	$15
Kyowa Kirin, Inc.	1	$14
Tanabe Pharma America, Inc.	1	$13
Endo Pharmaceuticals Inc.	1	$12
Biohaven Pharmaceuticals, Inc.	1	$12
Zyla Life Sciences, Inc.	1	$12

How this compares

$2,109 in reported general payments places this provider in the 85th percentile of 182 physical medicine & rehabilitation providers in Missouri.

See all physical medicine & rehabilitation providers in Missouri →

Medicare billing

Part B allowed, 2024

$46,411

Medicare patients

121

Services billed

562

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	14	$7,612
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	38	$929
Gabapentin	23	$697
ClopidogrelClopidogrel Bisulfate	21	$192
Tramadol Hcl	16	$156
Atorvastatin Calcium	22	$141

Paid to pharmacies, not to this prescriber.

Other physical medicine & rehabilitation in Jefferson City

Nathan KenyonJefferson City$24K
William ShawJefferson City$1K
Lizette AlvarezSaint Louis$182K
Heidi HunterCape Girardeau$150K
Constantine FotopoulosKansas City$91K
Joseph BurrisColumbia$75K
Alexander ChamessianCreve Coeur$55K
Jane EmersonColumbia$44K
Reza FaridColumbia$37K
Kunj PatelSaint Louis$17K

See the full list for Missouri →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →